Tenosynovial giant cell tumors as accidental findings after episodes of distortion of the ankle: two case reports
© Illian et al; licensee BioMed Central Ltd. 2009
Received: 6 May 2008
Accepted: 15 December 2009
Published: 15 December 2009
Tenosynovial giant cell tumors are benign tumors of uncertain pathogenesis. They occur in the joints, tendons and synovial bursas. Due to a high recurrence rate of up to 50%, some authors call a giant cell tumor a semimalignant tumor. To date, less than 10 cases of tenosynovial giant cell tumor of the ankle have been published in the international medical literature.
In this case report, we present two patients with localized tumors that were detected accidentally after the occurrence of ankle sprains with persisting pain in the joint. The tumors were resected by open marginal surgery and regular follow-up examinations were carried out.
We present an unusual occurrence of a tumor along with a possible follow-up strategy, which has not been previously discussed in the international literature.
A tenosynovial giant cell tumor (TGCT) is a benign tumor of uncertain pathogenesis. It occurs in the joints, tendons and synovial bursas. First described in the international literature by Jaffe et al.  in 1941, it has been given different names including nodular tenosynovitis or (pigmented) villonodular synovitis or tenosynovitis, and bursitis [1–5]. TGCT may be either localized or diffused. The localized type of the tumor is most commonly found in finger joints while subtypes of diffuse-type TGCT may be distinguished as intra-articular and extra-articular. The lesion may appear anywhere in the synovium, but in 80% to 90% of cases, it occurs in the hand joints, and infrequently in the knee and foot joints . Due to the high recurrence rate of up to 50%, a correct classification of the tumor is essential. As a result of this, and also of the possible malignant degeneration of the tumor, some call the TGCT a semimalignant tumor [5–8],.
There has been no indication so far that specific age groups or gender have a higher incidence rate of acquiring the tumor. Studies described by Somerhausen et al. show 28 cases of the tumor occurring among women and 22 such cases occurring in men, which clearly shows no significant difference in incidence (binomial test, p = 0.479). Furthermore, some authors assume that the lesions are caused by an unknown agent while others consider them to be neoplastic [9, 10, 2].
Histologically, the growth of fibroblastic cells is followed by a reactive proliferation of histiocytic cells in the reticuloendothelial system. After phagocytosis of erythrocytes the cells undergo a transformation into hemosiderin-laden macrophages that merge into giant cells .
Case report 1
Microscopically, the tumor was partially encapsulated and composed of round to polygonal cells. Some were spindle cells and some were multinucleated giant cells (Figure 2B). The diagnosis of localized tenosynovial giant cell tumor of the tendon sheath was confirmed on histopathology. Results of special stains indicated the presence of iron in both mononuclear and multinucleated giant cells in cytologic and histologic preparations.
Case report 2
A 29-year-old Caucasian woman originally suffered from a distortion of her upper left ankle more than six years prior to presentation. The patient developed a chronic instability with recurrent distortions following the conservative treatment she underwent. After the most recent distortion, a computed tomography (CT) scan revealed substantial cystic lesions in the trochlea of her talus, synovial reaction with foreign tissue in the neighboring capsule and signs of a villonodular inflammation of the synovial membrane. On physical examination upon admission, however, the patient's gait pattern and mobility showed no abnormalities.
A lateral instability caused by ligament insufficiency was consequently found. Lateral stress views showed a 15-degree clear space widening and a talar shift of more than 10 mm.
The patient underwent an arthroscopy of the left ankle. The tumor was resected via open surgery. The articular surface of the talus and the distal tibia showed an extensive four-degree defect of the cartilage. Arthrotomy showed a brownish yellow tumor that was mainly solid attached to the ventral synovial tissue. This was entirely removed through a marginal resection. Additionally, these defects were smoothened and microfractured. The ligamental structures were not rebuilt because of advanced arthrosis of the patient's upper ankle. No complications occurred after the operation and the histological analysis identified the tumor as a localized TGCT.
Follow-up examinations after three, six, 12 and 24 months showed no indication of a recurrence of the tumor. An MRI scan 24 months after the operation showed no new tumor growth. However, a recurring pain in the patient's upper left ankle made another arthroscopy necessary. This procedure showed that a fibrocartilage had formed but no hypertrophic synovia was found to be present.
TGCT is a tumor that surgeons or orthopedics rarely diagnose. The international literature cites less than 10 cases of TGCT in the ankle. An important characteristic of the tumor is its slow growth, which leads to its usual diagnosis only by coincidence. Differential diagnosis has to take a number of other tumors into account, including lipoma, ganglia or fibromas. Prior to an operation, it is usually very difficult to distinguish whether the tumor is benign or malignant.
In the first case discussed in this report, the patient was suffering from pain caused by an impingement syndrome at the ventral part of his ankle. The resection of the TGCT left the patient with no discomfort or pain.
In the second case, recurrent distortions led to an advanced arthrosis in the patient's upper ankle. The patient continued to feel discomfort even after the tumor had been removed; hence, the tumor was unlikely to have caused the symptoms she experienced. Clearly, the tumor in this patient was found only by coincidence. Ligament augmentation was not performed because of advanced arthrosis in the patient's upper ankle.
The therapy of choice consists of a resection of the tumor that follows the basic principles of oncology since the tumor has to be regarded as malignant until proven otherwise [6, 10–13]. A neoadjuvant or adjuvant therapy is not usually necessary .
The etiology of TGCT has been discussed rather controversially in the literature. Our patients presented with persisting pain in the joint after they experienced certain traumas. The tumors were only detected accidentally. In both cases, however, it remains unclear whether distortion or chronic irritation of the upper ankle may have caused or influenced the development of TGCT.
Since they are rather rare, soft tissue tumors are often either taken lightly or misdiagnosed all together [3, 13]. It is thus important to consider the presence of this type of tumor once common conditions such as trauma and degeneration have already been excluded.
In addition, regular follow-ups are vital due to the high recurrence rate of the tumor in up to 50% of documented cases. MRI is a very suitable technology for diagnosing and identifying a tumor. In the literature, however, no advice is given as to when the follow-up should take place. The cases discussed above were periodically reanalyzed clinically and with the use of sonography at three, six, nine and 12 months. From then on the patients were advised to attend an annual follow-up for five years afterwards. Another MRI will be done after two and five years. If the sonographic analysis shows an indication for a recurrence or if it shows unclear diagnostic findings, an MRI examination should also be performed.
Written informed consent was obtained from the patients for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
tenosynovial giant cell tumor
magnetic resonance imaging
Thanks to Dr. Janine B. Illian for making substantial contributions in conceiving the study and in interpreting available data.
- Jaffe HL, Lichtenstein L, Sufro CJ: Pigmented villonodular synovitis, bursitis, and tenosynovitis. Arch Pathol. 1941, 31: 731-765.Google Scholar
- Choudhury M, Jain R, Nagia A, Logani KB: Localized tenosynovial giant cell tumor of the tendon sheath. Acta Cytologica. 1999, 44: 443-446.Google Scholar
- Buchner M, Bernd L, Zahlten-Hinguranage , Sabo D: Knochen- und Weichteiltumoren des Fußes und Sprunggelenks. Chirurg. 2005, 76: 391-397. 10.1007/s00104-004-0963-0.View ArticlePubMedGoogle Scholar
- Gibbons CL, Khwaja HA, Cole AS, Cooke PH, Athanasou NA: Giant-cell tumour of the tendon sheath in the foot and ankle. J Bone Joint Surg Br. 2002, 84 (7): 1000-1003. 10.1302/0301-620X.84B7.13115.View ArticlePubMedGoogle Scholar
- Rao AS, Vigorita VJ: Pigmented villonodular synovitis (giant-cell tumor of the tendon sheath and synovial membrane): a review of 81 cases. J Bone Joint Surg. 1984, 66 (1): 76-94.PubMedGoogle Scholar
- Matthes G, Richter D, Ostermann PAW, Firemann J, Ekkernkamp A: Der benigne tenosynoviale Riesenzelltumor im Bereich des oberen Sprunggelenks. Unfallchirurg. 2000, 103: 479-481. 10.1007/s001130050569.View ArticlePubMedGoogle Scholar
- Frenkel H, Kluger KM: Das semimaligne Riesenzellsynovialom als Zufallsbefund bei einer offenen Luxationsfraktur des oberen Sprunggelenks. Beitr Orthop Traumatolog. 1989, 36: 380-384.Google Scholar
- Taylor KF, Yingsakmongkol W, Conard KA, Stanton RP: Multicentric giant cell tumor of bone: a case report and review of the literature. Clin Orthop Relat Res. 2003, 410: 267-273. 10.1097/01.blo.0000063784.32430.b0.View ArticlePubMedGoogle Scholar
- Kuhnen C, Müller KM, Rabstein S, Kasprzynski A, Herter P: Tenosynoviale Riesenzelltumor. Pathologe. 2005, 26: 96-110. 10.1007/s00292-004-0740-3.View ArticlePubMedGoogle Scholar
- Vasconez HC, Nisanci M, Lee EY: Giant cell tumour of the flexor tendon sheath of the foot. J Plast Reconstr Aesthet Surg. 2007Google Scholar
- Selek H, Ozer H, Turanli S, Erdem O: Giant cell tumor of the talar neck. J Am Podiatr Med Assoc. 2007, 97 (3): 225-228.View ArticlePubMedGoogle Scholar
- Somerhausen NSA, Fletcher CDM: Diffuse-type giant cell tumor: clinicopathologic and immunohistochemical analysis of 50 cases with extraarticular disease. Am J Surg Pathol. 2000, 24 (4): 479-492. 10.1097/00000478-200004000-00002.View ArticlePubMedGoogle Scholar
- Bisbinas I, De Silva U, Grimer RJ: Pigmented villonodular synovitis of the foot and ankle: a 12-year experience from a tertiary orthopedic oncology unit. J Foot Ankle Surg. 2004, 43 (6): 407-411. 10.1053/j.jfas.2004.09.002.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.